TY  - GEN
AU  - Foss,F M
AU  - Ihde,D C
AU  - Breneman,D L
AU  - Phelps,R M
AU  - Fischmann,A B
AU  - Schechter,G P
AU  - Linnoila,I
AU  - Breneman,J C
AU  - Cotelingam,J D
AU  - Ghosh,B C
TI  - Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome
SN  - 0732-183X
PY  - 1993///0107
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Male
KW  - Middle Aged
KW  - Mycosis Fungoides
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Pentostatin
KW  - Recombinant Proteins
KW  - Sezary Syndrome
KW  - Skin Neoplasms
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1200/JCO.1992.10.12.1907
ER  -